Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C21 plus standard of care vs placebo in hospitalized adults with COVID-19
2021-000264-29Phase 3Completed
- Sponsor
- Vicore Pharma
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing C21 plus standard of care with Placebo plus standard of care (2 arms). Primary endpoint: Proportion of subjects discharged from hospital and free of supplemental oxygen at Day 15. Started Jun 2021; status: completed.
02
Drugs
buloxibutid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2021-000264-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000264-29.